Drugplain

VESIcare LS 1 mg/mL

solifenacin succinate · SUSPENSION · Astellas Pharma US, Inc.

No Recall History
Plain English

Vesicare LS (solifenacin succinate) is a liquid medication taken by mouth used to treat overactive bladder symptoms such as frequent urination, urgency, and incontinence. It works by relaxing the bladder muscle to help improve bladder control.

Key Facts

Brand Name
VESIcare LS
Generic Name
solifenacin succinate
NDC Code (Product)
51248-250
Manufacturer
Astellas Pharma US, Inc.
Strength
1 mg/mL
Dosage Form
SUSPENSION
Route
ORAL
Marketing Status
Application #
NDA209529
Marketing Start
05/26/2020

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective3,610 reports
constipation1,622 reports
dry mouth1,620 reports
fatigue1,287 reports
off label use1,247 reports
fall1,231 reports
dizziness1,041 reports
nausea903 reports
headache865 reports
vision blurred789 reports

Frequently Asked Questions

What is VESIcare LS used for?

Vesicare LS (solifenacin succinate) is a liquid medication taken by mouth used to treat overactive bladder symptoms such as frequent urination, urgency, and incontinence. It works by relaxing the bladder muscle to help improve bladder control.

Is VESIcare LS a controlled substance?

VESIcare LS is not classified as a controlled substance by the DEA.

What is the generic name for VESIcare LS?

The generic name for VESIcare LS is solifenacin succinate. There are 12 other brand versions of solifenacin succinate.

What is the NDC code for VESIcare LS 1 mg/mL?

The NDC (National Drug Code) for VESIcare LS 1 mg/mL is 51248-250, listed by Astellas Pharma US, Inc..

Product NDC

51248-250

Package NDC

51248-250-99

Other Solifenacin Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)